Views provided by UsageCounts
Nuclear Pore Complex Proteins, Oncogene Proteins, Fusion, childhood, acute leukemia, Benzamides; Humans; Imatinib Mesylate; Nuclear Pore Complex Proteins; Oncogene Proteins, Fusion; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Benzamides, Imatinib Mesylate, Humans, Benzamides; Humans; Imatinib Mesylate; Nuclear Pore Complex Proteins; Oncogene Proteins; Fusion; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Nuclear Pore Complex Proteins, Oncogene Proteins, Fusion, childhood, acute leukemia, Benzamides; Humans; Imatinib Mesylate; Nuclear Pore Complex Proteins; Oncogene Proteins, Fusion; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Benzamides, Imatinib Mesylate, Humans, Benzamides; Humans; Imatinib Mesylate; Nuclear Pore Complex Proteins; Oncogene Proteins; Fusion; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 7 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
| views | 80 |

Views provided by UsageCounts